Journal: Research
Article Title: Epigenetic Suppression of RASAL1 by HDAC3 and Cofactor YY1 Promotes Fibroblast–Myofibroblast Transition and Renal Fibrosis
doi: 10.34133/research.1073
Figure Lengend Snippet: HDAC3 inhibition of Rasal1 transcription involves YY1. (A) Western blots of renal tissues from sham-, UUO (7 d)-, control-, and AAI (14 d)-treated mice ( n = 6) for YY1. The quantitation was on the right side. (B) Molecular docking between HDAC3 and YY1. The binding energy was analyzed by MM-GBSA. (C) Co-IP assay. Renal tissue homogenates from sham-, RG-, UUO-, or RG/UUO mice ( n = 6) were assayed for HDAC3 and YY1 as input controls (the bottom 3 blots). Subsequently, the same tissue lysates were immunoprecipitated with isoform-matched immunoglobulin (Ig) or antibodies (IPab) specific to HDAC3 (HD3) or YY1, and then immunoprecipitants were reciprocally assessed for HDAC3 and YY1 by Western blotting (the top 2 blots). (D) Quantification of Co-IP in (C). Data were presented as means ± SEM based on 3 renal samples from each group. (E) NRK-49F cells were transfected with control lentivirus (siC) and 3 YY1 knockdown lentiviruses (si1, si2, and si3) for 48 h. Western blotting was performed on cell lysates to measure YY1 protein levels. The bottom panel was the quantification of protein. (F) NRK-49F cells were transfected with control lentivirus (siC) and YY1 knockdown lentivirus (siR-Yy1, si3) for 24 h, followed by treatment with TGFβ (10 ng/ml) for additional 24 h. Cell lysates were assayed for RASAL1 and YY1 expression by Western blotting. (G) The top panel shows the YY1 binding motif sequence logo from JASPAR, while the bottom panel depicts a schematic diagram of YY1 binding to the Rasal1 promoter. TSS, transcription start site. (H) ChIP assay. The control, UUO, or AAI mice were treated with or without RG (10 mg/kg). The renal tissues indicated above were immunoprecipitated with antibodies to HDAC3, YY1 and Ac-H3, and then the precipitated genomic DNA (input) and the antibody-bound DNAs were PCR amplified with primers covering the YY1 motif on Rasal1 promoter. The RT-PCR products were analyzed on an agarose gel (left). RT-qPCR (right) was normalized to input DNA and presented as fold changes relative to sham. (I) Luciferase assay. HEK293T cells were transfected with the murine Rasal1 promoter reporter ( Rasal1 p-luc) or the m Rasal1 p-luc plus a Renilla luciferase plasmid. After 24 h of YY1 knockdown and control lentivirus treatment, cells were treated with TGFβ (10 ng/ml) for additional 24 h, and the luciferase activities were measured and normalized to Renilla luciferase activities. Data were presented as means ± SEM based on 6 renal samples or means ± SD of 3 repeated cell assays. * P < 0.05, one-way ANOVA (A and E), 2-way ANOVA (D, F, and H), or 3-way ANOVA (I).
Article Snippet: Human embryonic kidney (HEK) 293T cells (American Type Culture Collection, USA) were cultured in DMEM, and rat renal fibroblast NRK-49F cells (Procell Life Science & Technology, Wuhan, China) and mouse primary renal fibroblasts were cultured in DMEM/F12 medium.
Techniques: Inhibition, Western Blot, Control, Quantitation Assay, Binding Assay, Co-Immunoprecipitation Assay, Immunoprecipitation, Transfection, Knockdown, Expressing, Sequencing, Amplification, Reverse Transcription Polymerase Chain Reaction, Agarose Gel Electrophoresis, Quantitative RT-PCR, Luciferase, Plasmid Preparation